Counterpoints: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations?—No, EGFR TKIs should be reserved for patients with EGFR mutations Journal Article
| Author: | Riely, G. J. |
| Article Title: | Counterpoints: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations?—No, EGFR TKIs should be reserved for patients with EGFR mutations |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 14 |
| Issue: | 1 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2016-01-01 |
| Start Page: | 41, 44 |
| End Page: | 45 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 27057667 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 3 February 2016 -- Source: Scopus |
